Abstracts tagged "nutrition and systemic sclerosis"

Abstract Number: 2661 • 2017 ACR/ARHP Annual Meeting
Clinical Impact of Selenium and Vitamin C Deficiency in Systemic Sclerosis
Romain Dupont¹, Guillaume Moulis², Léonardo Astudillo³, Philippe Arlet⁴, Laurent Sailler⁵ and Grégory Pugnet⁶, ¹Service de médecine Interne, CHU purpan, Toulouse, France, ²CIC 1436, Toiulouse, France, ³Service de Médecine Interne, CHU Purpan, Toulouse, France, ⁴Service de Médecine Interne, CHU Purpan, Toulouse,, France, ⁵Medecine Interne, CHU Toulouse, Toulouse, France, ⁶Department of Internal Medicine, Toulouse University Hospital, University of Toulouse, INSERM UMR 1027, Toulouse, France
Background/Purpose: Malnutrition is a major concern in systemic sclerosis (SSc) however literature is scarce on the subject, especially on micronutriment or vitamin deficiency and its…
Abstract Number: 2432 • 2014 ACR/ARHP Annual Meeting
Nutritional Assessment in Patients with Systemic Lupus Erythematosus and Systemic Sclerosis
Sabrina Vagnani¹, Chiara Tani², Linda Carli³, Francesca Querci³, Alessandra Della Rossa³, Anna d'Ascanio^3,4, Ilaria Ermini⁵, Marco Ceroti⁵, Saverio Caini⁵, Domenico Palli⁵, Stefano Bombardieri⁶ and Marta Mosca³, ¹Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, ²Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, ³Rheumatology Unit, University of Pisa, Pisa, Italy, ⁴Internal Medicine, University of Pisa, Pisa, Italy, ⁵Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute, ISPO, Florence, Itay., Florence, Italy, ⁶Rheumatology Unit, Pisa, Italy
Background/Purpose Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) can be both associated with various degrees and types of malnutrition, with different pathogenetic mechanisms. It’s…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].